Nanotechnology Now - Press Release: Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their

Home > Press > Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their

Abstract:
Harris & Harris Group, Inc. (Nasdaq:TINY), reported today that, as of December 31, 2013, its net asset value and net asset value per share were $122,701,575 and $3.93, respectively. The Company's Annual Report on Form 10-K may be accessed at ir.hhvc.com/sec.cfm.

Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their

New York, NY | Posted on March 17th, 2014

SUMMARY OF FINANCIAL POSITION

December 31, 2013 December 31, 2012 September 30, 2013
(Audited) (Audited) (Unaudited)

Total Assets $125,063,946 $131,990,250 $133,075,280
Net Assets $122,701,575 $128,436,774 $130,233,967
Net Asset Value per Share $3.93 $4.13 $4.18
Shares Outstanding 31,197,438 31,116,881 31,159,256
Shareholders also may be interested to read our Annual Letter to Shareholders posted on our website at ir.hhvc.com/letters.cfm.

####

About Harris & Harris Group, Inc.
Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com and on Facebook at www.facebook.com/harrisharrisvc.

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2013, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references to the websites www.HHVC.com and www.Facebook.com, have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.

For more information, please click here

Contacts:
DOUGLAS W. JAMISON
(212) 582-0900

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: